Search clinical trials for: ARQ-252 cream 0.3%

Total 359 results

G & W Laboratories Inc.

Completed

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis

Atopic Dermatitis

Canada
Allergan

Terminated

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Shulov Innovate for Science Ltd. 2012

Completed

Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers

Healthy

Israel
Covis Pharma S.à.r.l.

Completed

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

Raynaud's Phenomenon Secondary to Connective Tissue Disease

United States
MediQuest Therapeutics

Unknown

Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Raynaud Disease

United States
Dr. Reddy's Laboratories Limited

Completed

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

Acne Vulgaris

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Lower Umfolozi Regional War Memorial Hospital

Completed

The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants

Pain

Norway, South Africa
Istituto Ganassini S.p.A. di Ricerche Biochimiche

Recruiting

Comparative Clinical Trial on Neoviderm Skin Emulsion and Connettivi-na 0.2% Cream to Evaluate the Normalization Process of the Skin and Re-duction of Cutaneous Tension and Pain in Patients With Superficial Burns Grade 1 and 2 (NVD01/22)

Dermatology

Italy
Novartis Pharmaceuticals

Completed

A First-in-Human Study of CEE321 in Adult Subjects

Atopic Dermatitis

United States, Japan
Galderma R&D

Completed

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Acne Vulgaris

United States
Neal Weintraub
University of Cincinnati

Terminated

Efficacy of Topical Capsaicin Cream for Stable Angina (TOPCAP)

Stable Angina

United States
Valeant Pharmaceuticals

Unknown

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Acne Vulgaris
Scioderm, Inc.
Amicus Therapeutics

Completed

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Epidermolysis Bullosa

Italy, Spain, Serbia, United States, Australia, Netherlands, Austria, Germany, Israel, Lithuania, France, United Kingdom, Poland
Cassiopea SpA

Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

Acne Vulgaris

United States, Georgia, Ukraine
Montefiore Medical Center

Withdrawn

Topical Steroids & Bacterial Decolonization for Radiation Dermatitis

Radiation Dermatitis

United States
Bayer

Terminated

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Psoriasis

Germany
Cassiopea SpA

Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

Acne Vulgaris

United States, Bulgaria, Georgia, Poland, Romania, Serbia
Carilion Clinic
Chorda Pharma, Inc.

Completed

Thermosensitivity of a Topical Palmitated Formulation of Capsaicin

Pain Management

United States
Aldeyra Therapeutics, Inc.

Completed

A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)

Sjögren-Larsson Syndrome

United States
Galderma R&D

Completed

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Dipexium Pharmaceuticals, Inc.

Completed

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (OneStep-2)

Diabetic Foot Infection

United States
Galderma R&D

Completed

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Tri-Service General Hospital

Completed

Fluid Restriction After Stapled Hemorrhoidopexy

Fluid Restriction

Taiwan
GlaxoSmithKline

Completed

Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264

Urticaria

Germany, United Kingdom
Dipexium Pharmaceuticals, Inc.

Completed

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (OneStep-1)

Diabetic Foot Infection

United States
Rabin Medical Center

Unknown

Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis

Rosacea | Demodicidosis

Israel
Topaz Pharmaceuticals Inc

Completed

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

Head Lice

United States
Fougera Pharmaceuticals Inc.

Completed

Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population

Psoriasis | Atopic Dermatitis

United States
Noah Rosenberg, MD

Completed

Neo-Synalar Modified 48 Hour Patch Test

Allergy

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
U.S. Army Medical Research and Development Command

Completed

Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)

Leishmaniasis, Cutaneous

Peru
University of California, Irvine
Beckman Laser Institute University of California Irvine; Unilever R&D

Completed

Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies

Collagen Fibril Alteration

United States
Allergan

Completed

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Acne Vulgaris

United States
MC2 Therapeutics

Completed

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

Vasoconstriction

France
Pierre Fabre Medicament

Completed

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

Atopic Dermatitis

Estonia, France, Lithuania, Poland, Romania
Galderma R&D

Completed

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Photoaging

United States
University of Aarhus

Completed

Effect of Intralymphatic Immunotherapy

Allergy | Immune Tolerance | Injection Site Discomfort

Denmark
Topaz Pharmaceuticals Inc

Completed

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects (LICE OUT)

Head Lice

United States
Vaxcyte, Inc.

Active, not recruiting

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

Pneumococcal Vaccines

United States
Aptose Biosciences Inc.

Completed

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumours

United States
Assiut University

Unknown

Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease

Nail Psoriasis
Northwestern University
Bayer

Terminated

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Rash | Hand-foot Skin Reaction

United States
U.S. Army Medical Research and Development Command

Completed

Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama

Leishmaniasis, Cutaneous

Panama
Graceway Pharmaceuticals, LLC

Completed

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Superficial Basal Cell Carcinoma

Australia, New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Dyslipidemias | Hypertriglyceridemia | Familial Hypercholesterolemia

Australia, New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Hypertriglyceridemia | Familial Chylomicronemia

Australia, Canada, New Zealand
Ventrus Biosciences, Inc

Unknown

Topical Safety Study of Topical Diltiazem Hydrochloride

Diltiazem Skin Sensitivity.

United States
University of Utah

Completed

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

Cancer | Lentigo Maligna

United States
University of Michigan

Completed

Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin

Purpura | Skin Aging

United States

3

Subscribe